Oventus Medical (OVN) Stock Price, News & Analysis

Company Overview

Oventus Medical Limited, a medical device company, engages in the development and commercialization of oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 289,932 shs
• Average Volume: N/A
• Market Capitalization: A$4.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OVN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Oventus Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Oventus Medical investors own include United Royale (URYL), MariMed (MRMD), ATI (ATI) and Alpha Lithium (APHLF).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:OVN
• CIK: N/A
• Web: www.oventus.com.au
• Phone: 61 7 3831 8866
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$10.29 million
• Net Margins: -916.66%
• Pretax Margin: N/A
• Return on Equity: -80.43%
• Return on Assets: -64.82%

Debt

• Debt-to-Equity Ratio: 4.27
• Current Ratio: 4.99
• Quick Ratio: 3.19

Sales & Book Value

• Annual Sales: A$1.09 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 5.11
• Book Value: A$0.08 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 241,730,000
• Free Float: N/A
• Market Cap: A$4.83 million
• Optionable: Not Optionable
• Beta: 0.66